The selective Cox-2 inhibitor Celecoxib suppresses angiogenesis and growth of secondary bone tumors: An intravital microscopy study in mice

被引:0
|
作者
Frank Michael Klenke
Martha-Maria Gebhard
Volker Ewerbeck
Amir Abdollahi
Peter E Huber
Axel Sckell
机构
[1] University of Bern,Department of Orthopedic Surgery, Inselspital
[2] University of Heidelberg,Department of Experimental Surgery
[3] INF 365,Department of Orthopaedic Surgery
[4] University of Heidelberg,Department of Trauma and Reconstructive Surgery
[5] German Cancer Research Center,undefined
[6] INF 280,undefined
[7] Charité – Campus Benjamin Franklin,undefined
来源
BMC Cancer | / 6卷
关键词
Vascular Endothelial Growth Factor; Bone Metastasis; Celecoxib; Tumor Implantation; Intravital Microscopy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Imatinib-resistant K562 cells are more sensitive to celecoxib, a selective COX-2 inhibitor: Role of COX-2 and MDR-1
    Arunasree, Kalle M.
    Roy, Karnati R.
    Anilkumar, Kotha
    Aparna, A.
    Reddy, Gorla Venkateswara
    Reddanna, Pallu
    LEUKEMIA RESEARCH, 2008, 32 (06) : 855 - 864
  • [42] Influence of the selective COX-2 inhibitor celecoxib on sex differences in blood pressure and albuminuria in spontaneously hypertensive rats
    Elmarakby, Ahmed A.
    Katary, Mohamed
    Pollock, Jennifer S.
    Sullivan, Jennifer C.
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2018, 135 : 16 - 20
  • [43] CYP2C9 GENOTYPE AND DOSE OPTIMIZATION OF CELECOXIB, A SELECTIVE COX-2 INHIBITOR, IN HEALTHY KOREANS
    Keum, S.
    Choi, C.
    Bae, J.
    Jang, C.
    Lee, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 : S45 - S45
  • [44] Expression of COX-2 and β-catenin in the large intestine of DMH-mice treated with the selective COX-2 inhibitor NS-398
    Banu, N
    Daly, R
    Moorghen, M
    Pignatelli, M
    JOURNAL OF PATHOLOGY, 2002, 198 : 28A - 28A
  • [45] The effect of celecoxib, a selective COX-2 inhibitor, on liver ischemia/reperfusion-induced oxidative stress in rats
    Ozturk, H
    Gezici, A
    Ozturk, H
    HEPATOLOGY RESEARCH, 2006, 34 (02) : 76 - 83
  • [46] Anti-gastric cancer effect of celecoxib, a selective COX-2 inhibitor, through inhibition of AKT signaling
    Kim, Nayoung
    Kim, Chung Hyun
    Park, Ji Hyun
    Lee, Mi Kyung
    Cho, Soo-Jeong
    Kim, Joo Sung
    Jung, Hyun Chae
    Song, In Sung
    GASTROENTEROLOGY, 2008, 134 (04) : A388 - A388
  • [47] Celecoxib, a selective COX-2 inhibitor, markedly reduced the severity of tamoxifen-induced adenomyosis in a murine model
    Jin, Zhixing
    Wu, Xiaoyi
    Liu, Haiou
    Xu, Congjian
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 19 (05) : 3289 - 3299
  • [48] Anti-gastric cancer effects of celecoxib, a selective COX-2 inhibitor, through inhibition of Akt signaling
    Kim, Nayoung
    Kim, Chung Hyun
    Ahn, Dong-Won
    Lee, Kyoung Soo
    Cho, Soo-Jeong
    Park, Ji Hyun
    Lee, Mi Kyoung
    Kim, Joo Sung
    Jung, Hyun Chae
    Song, In Sung
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 (03) : 480 - 487
  • [49] COX-2-selective inhibitor, etodolac, suppresses choroidal neovascularization in a mice model
    Takahashi, H
    Yanagi, Y
    Tamaki, Y
    Uchida, S
    Muranaka, K
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 325 (02) : 461 - 466
  • [50] The effect of cyclooxygenase-2 (COX-2) inhibitor, Celecoxib, on xenograft of hepatocellular carcinoma (HCC) in nude mice.
    Tang, TC
    Poon, RT
    Guan, XY
    Fan, ST
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6149S - 6149S